Key points are not available for this paper at this time.
Within a multidisciplinary model of care, the treatment of HCV-infected PWID with all-oral DAA regimens is safe and highly effective. These data justify targeted efforts to enhance access to HCV treatment in this vulnerable and marginalized population.
Alimohammadi et al. (Wed,) studied this question.